Fundraising Fox

Dario Doller

Founder

Co-founder at Modulate Bio

New York City Metropolitan Area

FoundedModulate Bio

About

Dario Doller is Chief Scientific Officer at Modulate Bio, with expertise in allosteric drug discovery targeting GPCRs, ion channels, and enzymes for CNS, metabolic, and cardiovascular indications. Over a 30-year career in pharma and biotech, he contributed to the FDA-approved drug Vorapaxar and to four additional clinical-stage compounds (CTP-692, NGD-4715, and Lu AF09535), and edited two books, Allosterism in Drug Discovery (RSC, 2017) and Trends in CNS Drug Discovery (Wiley, 2025). His background spans medicinal chemistry, CNS chemical biology, pharmacokinetics, and in vitro and in vivo pharmacology.

Co-founder at Modulate Bio

Intro paths

→

In turn, Dario can intro founders to Modulate Bio's investors below.

Modulate Bio's investors · 1

Pillar VCBoston · $50K – $4M checks

Co-founders at Modulate Bio

KHKevin Hodgetts
Kevin HodgettsFounding Lab / Co-founder

Experience

  1. Modulate BioChief Scientific Officer (CSO)current2023 — presentMassachusetts, United States
  2. Nabu TherapeuticsVP of Medicinal Chemistrycurrent2025 — presentSan Francisco Bay Area
  3. Babylon BiosciencesDiscovery Teamcurrent2025 — presentSan Francisco Bay Area
  4. Alcyoneus ScienceWorksEarly discovery consulting2015 — 2025NJ, USA
  5. iNeuro Therapeutics IncVP Chemistry2022 — 2023Cambridge, Massachusetts, United States
  6. Lucy TherapeuticsVP, Drug Discovery2021 — 2022Cambridge, Massachusetts, United States
  7. Sunovion PharmaceuticalsDirector, Medicinal Chemistry2019 — 2021Marlborough, MA
  8. Sage TherapeuticsSenior Director, Head of Exploratory Research2017 — 2019Cambridge, MA
  9. CoNCERT Pharmaceuticals, Inc.Senior Director, Deuterium Platform2016 — 2017Greater Boston
  10. LundbeckChemical Biology, Global Head2014 — 2015Paramus, NJ
  11. LundbeckDirector, Global Project Leader (Discovery Chemistry & DMPK Department)2011 — 2014Paramus, NJ
  12. LundbeckDirector, Medicinal Chemistry (Chemical and Pharmacokinetic Sciences Department)2010 — 2011
  13. LundbeckDirector, Medicinal Chemistry2006 — 2010
  14. Neurogen CorporationAssociate Director2000 — 2006
  15. GliatechSenior Scientist1999 — 2000
  16. 3-Dimensional PharmaceuticalsGroup Leader1998 — 1999
  17. Schering-Plough Research InstituteSenior Scientist1994 — 1998
  18. Rohm and HaasResearch Scientist1992 — 1994Springhouse, PA
  19. Texas A&M UniversityPost-doc1989 — 1992

Skills & more

Biomarker Discovery6Translational MedicineBusiness DevelopmentAnalytical SkillsGritStructural BiologyScenario PlanningOut-licensingIn-licensingDevelopment ProgramsDrug Discovery99Medicinal Chemistry99
+12 moreDrug DesignPharmacologyDrug DevelopmentBiotechnologyChemistryNeuroscienceDMPKPharmacokineticsGPCRsAssay DevelopmentCollaborative Problem SolvingCreative Solutions

Languages Spanish

From Dario's professional profile.

Frequently asked questions

Who is Dario Doller?
Dario Doller is Chief Scientific Officer at Modulate Bio, with expertise in allosteric drug discovery targeting GPCRs, ion channels, and enzymes for CNS, metabolic, and cardiovascular indications. Over a 30-year career in pharma and biotech, he contributed to the FDA-approved drug Vorapaxar and to four additional clinical-stage compounds (CTP-692, NGD-4715, and Lu AF09535), and edited two books, Allosterism in Drug Discovery (RSC, 2017) and Trends in CNS Drug Discovery (Wiley, 2025). His background spans medicinal chemistry, CNS chemical biology, pharmacokinetics, and in vitro and in vivo pharmacology.
Where does Dario Doller work?
Dario Doller is Co-founder of Modulate Bio.
What companies did Dario Doller found?
Dario Doller founded Modulate Bio.
Where did Dario Doller go to school?
Dario Doller studied at University of Buenos Aires (Doctor of Philosophy - PhD, Chemical Sciences); University of Buenos Aires (Licentiate degree, Organic Chemistry).

Founder mafias

University of Buenos Aires mafia26

Also came through, then founded or led a company.

Cameron McLainStudy AbroadFounded MeadowErnesto DoudchitzkyIngeniero en programaciónFounded ChattigoMariano WernerLawyerFounded ExamediKevin JanzenIncompleteFounded GlobantGustavo MahlerPhDFounded NcardiaMatias WoloskiIngenieria en InformaticaFounded Auth0

+ 19 more

Sage Therapeutics mafia4

Also came through, then founded or led a company.

Steve PaulDirectorFounded Voyager Therapeutics, Inc. +1Jamil BegSenior Director, Business Development & Brand LeaderFounded Nido Biosciences +1Kiran ReddyChief Business OfficerFounded Praxis Precision Medicines

Same school

Also attended University of Buenos Aires119

Arturo LitvinHead of Global Portfolio Development at Intel CapitalJonas VetterleInvestor at Moonfire VenturesCameron McLainBuilding things that endure, and living fully along the way.Marta CruzCo-Founder and Managing Partner of NXTP VenturesEduardo RazzettiChief Financial Officer at NXTPAgustina ChaarAccounting and Treasury Analyst at NXTP

+ 113 more

Shared employers

Also worked at Lucy Therapeutics1

Benjamin LiVice President at Pivotal Life Sciences

Also worked at Sunovion Pharmaceuticals2

Kaitlyn LagascaManager, Talent Acquisition at Anzu PartnersShwen GweeDigital Pharma Advisor at Excelerate Health Ventures

Also worked at Sage Therapeutics6

Jeffrey M. JonasPartner at Cure VenturesAlbert J. RobichaudPartner at Cure VenturesKiran ReddySenior Managing Director at Blackstone Life SciencesJamil BegPartner at 5AM VenturesAsha NayakInvestor at Johnson & Johnson Innovation – JJDCMatthew CalistriManaging Director at Bain Capital Life Sciences

Also worked at Schering-Plough Research Institute10

Andrea van ElsasInvestor at Third Rock VenturesDesmond PadhiOperating Partner at Westlake Village BioPartnersLance BermanVenture Partner at Ysios CapitalJean-François FormelaPartner at Atlas VentureT S AnantakrishnanManaging Partner at Varanium Capital AdvisorsVishal BajpaiPartner, Business Development at Varanium Capital Advisors

+ 4 more